Lilly to sell obesity drugs directly on Hims & Hers site Reuters
Lilly to sell obesity drugs directly on Hims & Hers site - Reuters
In short
Eli Lilly will sell its obesity drugs directly through the Hims & Hers platform. The move allows the pharmaceutical company to distribute the treatments through the telehealth and wellness site. This integration connects the drugmaker's therapies with the digital platform's customer base. As a result, patients seeking weight-loss solutions can obtain the treatments straight from the online provider.
Key points
- Patients can access targeted obesity therapies directly through a dedicated telehealth pl…: Patients can access targeted obesity therapies directly through a dedicated telehealth platform.
- Eli Lilly expands the direct digital distribution of its proprietary weight-loss treatmen…: Eli Lilly expands the direct digital distribution of its proprietary weight-loss treatments.
- The digital wellness channel now acts as a distribution vehicle for major pharmaceutical…: The digital wellness channel now acts as a distribution vehicle for major pharmaceutical therapies.